Literature DB >> 10335783

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

M I Schmidt1, B B Duncan, A R Sharrett, G Lindberg, P J Savage, S Offenbacher, M I Azambuja, R P Tracy, G Heiss.   

Abstract

BACKGROUND: Type 2 diabetes mellitus and atherosclerotic cardiovascular disease have common antecedents. Since markers of inflammation predict coronary heart disease and are raised in patients with type 2 diabetes, we investigated whether they predict whether people will develop type 2 diabetes.
METHODS: 12,330 men and women, aged 45-64 years, were followed up for a mean of 7 years. We analysed the association between different markers of acute inflammation and subsequent diagnosis of diabetes. In a subgroup of 610 individuals selected originally for an unrelated atherosclerosis case-control study, we also investigated diabetes associations with total sialic acid and orosomucoid, haptoglobin, and alpha1-antitrypsin.
FINDINGS: 1335 individuals had a new diagnosis of diabetes. Adjusted odds ratios for developing diabetes for quartile extremes were 1.9 (95% CI 1.6-2.3) for raised white-cell count, 1.3 (1.0-1.5) for low serum albumin, and 1.2 (1.0-1.5) for raised fibrinogen. In the subgroup analysis, individuals with concentrations of orosomucoid and sialic acid of more than the median had odds ratios of 7.9 (2.6-23.7) and 3.7 (1.4-9.8), respectively. Adjustment for body-mass index and waist-to-hip ratio lessened the associations; those for white-cell count (1.5 [1.3-1.8]), orosomucoid (7.1 [2.1-23.7]), and sialic acid (2.8 [1.0-8.1]) remained significant.
INTERPRETATION: Markers of inflammation are associated with the development of diabetes in middle-aged adults. Although autoimmunity may partly explain these associations, they probably reflect the pathogenesis of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335783     DOI: 10.1016/s0140-6736(99)01046-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  273 in total

Review 1.  Genetic determinants of diabetes and atherosclerosis.

Authors:  Braxton D Mitchell; Ikhide G Imumorin
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

2.  Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis.

Authors:  H Bruunsgaard; P Skinhøj; A N Pedersen; M Schroll; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Mitigating cellular inflammation in older adults: a randomized controlled trial of Tai Chi Chih.

Authors:  Michael R Irwin; Richard Olmstead
Journal:  Am J Geriatr Psychiatry       Date:  2012-09       Impact factor: 4.105

Review 4.  Cardiovascular risk associated with the metabolic syndrome.

Authors:  Robert S Lindsay; Barbara V Howard
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 5.  Endothelial dysfunction and the metabolic syndrome.

Authors:  Gary E McVeigh; Jay N Cohn
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 6.  Endothelial dysfunction, inflammation and diabetes.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 7.  Preventing diabetes by treating aspects of the metabolic syndrome.

Authors:  Roopa Sathyaprakash; Robert R Henry
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 8.  Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.

Authors:  Milagros G Huerta; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 9.  It's reticulated: the liver at the heart of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Sunil K Noothi; Michelle C Flynn; Andrew J Murphy
Journal:  J Endocrinol       Date:  2018-05-02       Impact factor: 4.286

10.  Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.

Authors:  Ilvira M Khan; Yashashwi Pokharel; Razvan T Dadu; Dorothy E Lewis; Ron C Hoogeveen; Huaizhu Wu; Christie M Ballantyne
Journal:  J Clin Endocrinol Metab       Date:  2016-08-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.